Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01985932 · ClinicalTrials.gov registry record · NA

Functional MRI Use in Prostate Radiation Treatment Planning

A NA study, sponsored by Abramson Cancer Center at Penn Medicine.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT01985932: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.

NCT01985932 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01985932, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

This study is being done to evaluate the use of MRI during radiation treatment planning to identify areas of tumor within the prostate to aid in future treatment planning and targeting of prostate cancer. This study will be conducted at the University of Pennsylvania Health System. The study is projected to run for 18 months. Subjects will be male 18 or older with a prostate cancer diagnosis and treatment plansat the Department of Radiation Oncology.

Interventions

  • DEVICE MRI

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2012-07
Est. Completion 2015-12
Phase NA

What the finished NCT01985932 record still lists

NCT01985932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.

NCT01985932 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01985932 about?

NCT01985932 is a clinical study titled "Functional MRI Use in Prostate Radiation Treatment Planning". This study is being done to evaluate the use of MRI during radiation treatment planning to identify areas of tumor within the prostate to aid in future treatment planning and targeting of prostate cancer. This study will be conducted at the University of Pennsylvania Health System. The study is proj...

What is the current status of trial NCT01985932?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2012-07. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01985932?

The interventions under investigation include: MRI (DEVICE).

Who is sponsoring clinical trial NCT01985932?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01985932's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01985932, the US trial registry maintained by the National Library of Medicine. NCT01985932 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.